24SQ
Human HRAS WT (GDP-bound) in complex with macrocyclic peptide inhibitor AP6296
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SPRING-8 BEAMLINE BL45XU |
| Synchrotron site | SPring-8 |
| Beamline | BL45XU |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2024-10-16 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.99999 |
| Spacegroup name | C 1 2 1 |
| Unit cell lengths | 135.935, 48.772, 65.546 |
| Unit cell angles | 90.00, 109.53, 90.00 |
Refinement procedure
| Resolution | 64.057 - 1.080 |
| R-factor | 0.1891 |
| Rwork | 0.188 |
| R-free | 0.20610 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Data reduction software | XDS (Jan 31, 2020) |
| Data scaling software | Aimless (0.7.15) |
| Phasing software | PHASER (2.8.3) |
| Refinement software | PHENIX (1.21.2_5419) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 64.057 | 64.057 | 1.199 |
| High resolution limit [Å] | 1.076 | 3.374 | 1.076 |
| Rmerge | 0.070 | 0.044 | 0.883 |
| Rmeas | 0.079 | 0.050 | 1.015 |
| Rpim | 0.036 | 0.022 | 0.492 |
| Total number of observations | 542086 | 28401 | 23867 |
| Number of reflections | 117556 | 5878 | 5878 |
| <I/σ(I)> | 10.2 | 29.56 | 1.6 |
| Completeness [%] | 93.5 | 100 | 68.5 |
| Completeness (spherical) [%] | 67.2 | 100.0 | 12.2 |
| Completeness (ellipsoidal) [%] | 93.5 | 100.0 | 68.5 |
| Redundancy | 4.61 | 4.83 | 4.06 |
| CC(1/2) | 0.997 | 0.996 | 0.639 |
| Anomalous completeness (spherical) | 65.3 | 99.9 | 11.5 |
| Anomalous completeness | 91.6 | 99.9 | 67.7 |
| Anomalous redundancy | 2.4 | 2.5 | 2.1 |
| CC(ano) | -0.297 | -0.389 | -0.035 |
| |DANO|/σ(DANO) | 0.7 | 0.6 | 0.6 |
| Diffraction limits | Principal axes of ellipsoid fitted to diffraction cut-off surface |
| 1.076 Å | 0.998, 0.998, 0.998 |
| 1.323 Å | 0.000, 0.000, 0.000 |
| 1.230 Å | 0.067, 0.067, 0.067 |
| Criteria used in determination of diffraction limits | local <I/sigmaI> ≥ 1.2 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.2M Magnesium acetate, 20.0% (w/v) Polyethylene glycol 3350 |






